Cutaneous leishmaniasis in red kangaroos: Isolation and characterisation of the causative organisms

International Journal for Parasitology

Volumn 34, Issue 6, 2004, Pages 655-664

  Rose, K ^a   Curtis, J ^b   Baldwin, T ^b   Mathis, A ^c   Kumar, B ^b   Sakthianandeswaren, A ^b   Spurck, T ^d   Low Choy, J ^e   Handman, E ^b  

^a Australian Registry of Wildlife Health   (Australia)

^b WALTER AND ELIZA HALL INSTITUTE OF MEDICAL RESEARCH   (Australia)

^c UNIVERSITY OF ZURICH   (Switzerland)

^d UNIVERSITY OF MELBOURNE   (Australia)

^e Parks and Wildlife Service of the Northern Territory   (Australia)

Author keywords

Cutaneous leishmaniasis; Kangaroo; Leishmania; Macropus rufus

Indexed keywords

GLYCAN DERIVATIVE; LIPOPHOSPHOGLYCAN; PROTEOPHOSPHOGLYCAN; RIBOSOME RNA; UNCLASSIFIED DRUG;

LEISHMANIASIS; MARSUPIAL;

ANIMAL MODEL; ARTICLE; AUSTRALIA; CONTROLLED STUDY; DISEASE TRANSMISSION; ENDEMIC DISEASE; GENE LOCUS; HISTOPATHOLOGY; HUMAN; IN VITRO STUDY; KANGAROO; MACROPHAGE; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PARASITE ISOLATION; POLYMERASE CHAIN REACTION; SKIN LEISHMANIASIS;

ANIMALS; ANTIBODIES, PROTOZOAN; BASE SEQUENCE; DNA, PROTOZOAN; LEISHMANIA; LEISHMANIASIS, CUTANEOUS; MACROPHAGES; MACROPODIDAE; MICROSCOPY, ELECTRON; MOLECULAR SEQUENCE DATA; RNA, PROTOZOAN; RNA, RIBOSOMAL; SKIN; SKIN ULCER;

AUSTRALASIA; AUSTRALIA;

ANIMALIA; MACROPODIDAE; MACROPUS; MACROPUS RUFUS; MACROPUS SP.;

EID: 1942445367     PISSN: 00207519     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijpara.2004.03.001     Document Type: Article

References (38)

1. Antoine J.C., Prina E., Jouanne C., Bongrand P. Parasitophorous vacuoles of Leishmania amazonensis-infected macrophages maintain an acidic pH. Infect. Immun. 58:1990;779-787.
2. Ashford R.W. The leishmaniases as emerging and reemerging zoonoses. Int. J. Parasitol. 30:2000;1269-1281.
3. Ashford R.W., Desjeux P., de Raadt P. Estimation of population at risk of infection and number of cases of leishmaniasis. Parasitol. Today. 8:1992;104-105.
4. Badaro R., Jones T.C., Carvalho E.M., Sampaio D., Reed S.G., Barral A., Teixeira R., Johnson W. Jr. New perspectives on a subclinical form of visceral leishmaniasis. J. Infect. Dis. 154:1986;1003-1011.
5. Chaffai M., Ben R.M., Ben I.R., Ben O.A., Makni N. Clinico-epidemiologic forms of cutaneous leishmaniasis in Tunisia. Ann. Dermatol. Venereol. 115:1988;1255-1260.
6. Chevalier B., Carmoi T., Sagui E., Charrette P., Petit D., Mauleon P., de Pouriere M., Marinie C., Didier C. Report of the first cases of cutaneous leishmaniasis in East Timor. Clin. Infect. Dis. 30:2000;840.
7. Croan D.G., Morrison D.A., Ellis J.T. Evolution of the genus Leishmania revealed by comparison of DNA and RNA polymerase gene sequences. Mol. Biochem. Parasitol. 89:1997;149-159.
8. El Tai N.O., Osman O.F., El Fari M., Presber W., Schönian G. Genetic heterogeneity of ribosomal internal transcribed spacer in clinical samples of Leishmania donovani spotted on filter paper as revealed by single-strand conformation polymorphism and sequencing. Trans. R. Soc. Trop. Med. Hyg. 94:2000;575-579.
9. Enserink M. Has Leishmaniasis become endemic in the US? Science. 290:2000;1881-1883.
10. Fernandes O., Murthy V.K., Kurath U., Degrave W.M., Campbell D.A. Mini-exon gene variation in human pathogenic Leishmania species. Mol. Biochem. Parasitol. 66:1994;261-271.
11. Handman E. Cell biology of Leishmania. Adv. Parasitol. 44:1999;1-39.
12. Handman E. Leishmaniasis: current status of vaccine development. Clin. Microbiol. Rev. 14:2001;229-243.
13. Handman E., Hocking R.E. Stage-specific, strain-specific, and cross reactive antigens of Leishmania species identified by monoclonal antibodies. Infect. Immun. 37:1982;28-33.
14. Herwaldt B.L. Leishmaniasis. Lancet. 354:1999;1191-1199.
15. Ilg T. Proteophosphoglycans of Leishmania. Parasitol. Today. 16:2000;489-497.
16. Ilg T., Menz B., Winter G., Russell D.G., Etges R., Schell D., Overath P. Monoclonal antibodies to Leishmania mexicana promastigote antigens. I. Secreted acid phosphatase and other proteins share epitopes with lipophosphoglycan. J. Cell. Sci. 99:1991;175-180.
17. Ilg T., Harbecke D., Wiese M., Overath P. Monoclonal antibodies directed against Leishmania secreted acid phosphatase and lipophosphoglycan. Partial characterization of private and public epitopes. Eur. J. Biochem. 217:1993;603-615.
18. Ilg T., Montgomery J., Stierhof Y.D., Handman E. Molecular cloning and characterization of a novel repeat-containing Leishmania major gene, ppg1, that encodes a membrane-associated form of proteophosphoglycan with a putative glycosylphosphatidylinositol anchor. J. Biol. Chem. 274:1999;31410-31420.
19. Ilgoutz S.C., McConville M.J. Function and assembly of the Leishmania surface coat. Int. J. Parasitol. 31:2001;899-908.
20. Kelleher M., Curtis J.M., Sacks D.L., Handman E., Bacic A. Epitope mapping of monoclonal antibodies directed against lipophosphoglycan of Leishmania major promastigotes. Mol. Biochem. Parasitol. 66:1994;187-200.
21. Kunz W. When is a parasite species a species? Trends Parasitol. 18:2002;121-124.
22. Ladds P.W., Donovan J.A., Reynolds A., Turton J.A. Giant cell enteritis in young crocodiles. Aust. Vet. J. 71:1994;300-301.
23. Marfurt J., Niederweiser I., Makia N.D., Beck H.P., Felger I. Diagnostic genotyping of Old and New World Leishmania species by PCR-RFLP. Diagn. Microbiol. Infect. Dis. 46:2003;115-224.
24. Mathis A., Deplazes P. PCR and in vitro cultivation for detection of Leishmania spp. in diagnostic samples from humans and dogs. J. Clin. Microbiol. 33:1995;1145-1149.
25. McCoy K.D. Sympatric speciation in parasites - what is sympatry? Trends Parasitol. 19:2003;400-404.
26. Montgomery J., Curtis C., Handman E. Genetic and structural heterogeneity of proteophosphoglycan in Leishmania. Mol. Biochem. Parasitol. 121:2002;75-85.
27. Nicolle C.H. Cultures des corps de Leishman isoles de la rate dans trois cas d'anemic splenique infantile. Bull. Soc. Pathol. Exot. 1:1908;121.
28. Pan A.A., Duboise S.M., Eperon S., Rivas L., Hodgkinson V., Traub-Cseko Y., McMahon-Pratt D. Developmental life cycle of Leishmania - cultivation and characterization of cultured extracellular amastigotes. J. Euk. Microbiol. 40:1993;213-223.
29. Sacks D.L. Developmental biology of Leishmania promastigotes. The Biology of Parasitism. 1988;Alan R. Liss, Inc. New York. pp. 93-103.
30. Shaw J.J. Animal reservoirs of Leishmania in different ecological situations and their importance in the epidemiology of the disease. Mem. Inst. Oswaldo Cruz. 1:1988;486-490.
31. Shaw J.J. Taxonomy of the genus Leishmania: present and future trends and their implications. Mem. Inst. Oswaldo Cruz. 89:1994;471-478.
32. Stein B., Dyce A.L. Field observations on the phlebotomine sand fly Australophlebotomus mackerrasi Lewis and Dyce feeding on the Gidgee skink Egernia stokesii Gray. Parasitol. Res. 88:2002;278-279.
33. Stierhof T.-D., Schwarz H., Menz B., Russell D.G., Quinten M., Overath P. Monoclonal antibodies to Leishmania mexicana promastigote antigens. II. Cellular localization of antigens in promastigotes and infected macrophages. J. Cell Sci. 99:1991;181-186.
34. Stierhof Y.-D., Ilg T., Russell D.G., Hohenberg H., Overath P. Characterization of polymer release from the flagellar pocket of Leishmania mexicana promastigotes. J. Cell Biol. 125:1994;321-331.
35. Stierhof Y.D., Bates P.A., Jacobson R.L., Rogers M.E., Schlein Y., Handman E., Ilg T. Filamentous proteophosphoglycan secreted by Leishmania promastigotes forms gel-like three-dimensional networks that obstruct the digestive tract of infected sandfly vectors. Eur. J. Cell Biol. 78:1999;675-689.
36. Turco S.J. The leishmanial lipophosphoglycan: a multifunctional molecule. Exp. Parasitol. 70:1990;241-245.
37. Turco S.J. Adversarial relationship between the Leishmania lipophosphoglycan and protein kinase C of host macrophages. Parasite Immunol. 21:1999;597-600.
38. Turco S.J., Späth G.F., Beverley S.M. Is lipophosphoglycan a virulence factor? A surprising diversity between Leishmania species. Trends Parasitol. 17:2001;223-226.